Open access
Jan 2026
Integrative Multiomics Analysis Reveals a Cancer Stem Cell–Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma
This study establishes a novel CSC–associated gene signature for diagnosis and prognosis in HCC and nominates belinostat as a repurposing candidate for targeting stemness‐related pathways, offering a promising strategy for personalized therapy.
Yang Zi, Ying Zhang, Jun Wu et al.
· Stem Cells International · 0 citations